Current potential of antisense oligonucleotides as therapeutic drugs
- 30 April 1994
- journal article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 4 (2) , 51-55
- https://doi.org/10.1016/1050-1738(94)90009-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Nonionic Oligonucleotide Analogs (Matagen™) as Anticodic Agents in Duplex and Triplex FormationAnnals of the New York Academy of Sciences, 1992
- Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivoNature, 1992
- Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro.Circulation Research, 1992
- Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense OligodeoxynucleotidesScience, 1991
- Novel route to oligo(deoxyribonucleoside phosphorothioates). Stereocontrolled synthesis of P-chiral oligo(deoxyribonucleoside phosphorothioates)Nucleic Acids Research, 1991
- Octa(thymidine methanephosphonates) of partially defined stereochemistry: synthesis and effect of chirality at phosphorus on binding to pentadecadeoxyriboadenylic acidNucleic Acids Research, 1990
- Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotideBiochemistry, 1989